![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PRR14L |
Gene summary for PRR14L |
![]() |
Gene information | Species | Human | Gene symbol | PRR14L | Gene ID | 253143 |
Gene name | proline rich 14 like | |
Gene Alias | C22orf30 | |
Cytomap | 22q12.2 | |
Gene Type | protein-coding | GO ID | NA | UniProtAcc | Q5THK1 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
253143 | PRR14L | LZE2T | Human | Esophagus | ESCC | 3.27e-05 | 3.97e-01 | 0.082 |
253143 | PRR14L | LZE4T | Human | Esophagus | ESCC | 6.63e-10 | 2.81e-01 | 0.0811 |
253143 | PRR14L | LZE7T | Human | Esophagus | ESCC | 1.52e-07 | 3.33e-01 | 0.0667 |
253143 | PRR14L | LZE8T | Human | Esophagus | ESCC | 5.89e-04 | 1.83e-01 | 0.067 |
253143 | PRR14L | LZE22T | Human | Esophagus | ESCC | 8.58e-04 | 2.63e-01 | 0.068 |
253143 | PRR14L | LZE24D1 | Human | Esophagus | HGIN | 4.10e-02 | 5.67e-01 | 0.054 |
253143 | PRR14L | LZE24T | Human | Esophagus | ESCC | 3.32e-12 | 3.37e-01 | 0.0596 |
253143 | PRR14L | LZE21T | Human | Esophagus | ESCC | 1.83e-03 | 2.59e-01 | 0.0655 |
253143 | PRR14L | P1T-E | Human | Esophagus | ESCC | 5.80e-24 | 5.82e-01 | 0.0875 |
253143 | PRR14L | P2T-E | Human | Esophagus | ESCC | 9.74e-22 | 3.89e-01 | 0.1177 |
253143 | PRR14L | P4T-E | Human | Esophagus | ESCC | 3.96e-08 | 1.39e-01 | 0.1323 |
253143 | PRR14L | P8T-E | Human | Esophagus | ESCC | 5.00e-17 | 2.90e-01 | 0.0889 |
253143 | PRR14L | P9T-E | Human | Esophagus | ESCC | 2.13e-19 | 2.54e-01 | 0.1131 |
253143 | PRR14L | P10T-E | Human | Esophagus | ESCC | 4.16e-22 | 3.76e-01 | 0.116 |
253143 | PRR14L | P11T-E | Human | Esophagus | ESCC | 1.68e-09 | 3.45e-01 | 0.1426 |
253143 | PRR14L | P12T-E | Human | Esophagus | ESCC | 9.74e-22 | 3.06e-01 | 0.1122 |
253143 | PRR14L | P15T-E | Human | Esophagus | ESCC | 1.45e-20 | 4.17e-01 | 0.1149 |
253143 | PRR14L | P16T-E | Human | Esophagus | ESCC | 7.52e-23 | 3.46e-01 | 0.1153 |
253143 | PRR14L | P17T-E | Human | Esophagus | ESCC | 5.89e-12 | 3.84e-01 | 0.1278 |
253143 | PRR14L | P19T-E | Human | Esophagus | ESCC | 4.78e-02 | 2.32e-01 | 0.1662 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PRR14L | SNV | Missense_Mutation | novel | c.949N>T | p.Gly317Cys | p.G317C | Q5THK1 | protein_coding | deleterious(0) | probably_damaging(0.911) | TCGA-AX-A2HC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | PD |
PRR14L | SNV | Missense_Mutation | novel | c.500N>C | p.Lys167Thr | p.K167T | Q5THK1 | protein_coding | tolerated(0.19) | benign(0.012) | TCGA-AX-A2HC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | PD |
PRR14L | SNV | Missense_Mutation | novel | c.5770C>T | p.Pro1924Ser | p.P1924S | Q5THK1 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AX-A2HD-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
PRR14L | SNV | Missense_Mutation | novel | c.243G>T | p.Glu81Asp | p.E81D | Q5THK1 | protein_coding | tolerated(0.23) | benign(0.015) | TCGA-AX-A2HD-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
PRR14L | SNV | Missense_Mutation | novel | c.5528N>C | p.Ser1843Thr | p.S1843T | Q5THK1 | protein_coding | deleterious(0.01) | probably_damaging(0.911) | TCGA-AX-A3FT-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
PRR14L | SNV | Missense_Mutation | novel | c.6141A>G | p.Ile2047Met | p.I2047M | Q5THK1 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AX-A3GB-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Chemotherapy | carboplatin | SD |
PRR14L | SNV | Missense_Mutation | rs769926993 | c.4238N>T | p.Thr1413Met | p.T1413M | Q5THK1 | protein_coding | tolerated(0.26) | benign(0.003) | TCGA-B5-A0JY-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | doxorubicin | SD |
PRR14L | SNV | Missense_Mutation | c.4380N>T | p.Gln1460His | p.Q1460H | Q5THK1 | protein_coding | tolerated(0.24) | possibly_damaging(0.539) | TCGA-B5-A11E-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
PRR14L | SNV | Missense_Mutation | novel | c.6167N>T | p.Pro2056Leu | p.P2056L | Q5THK1 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-B5-A1MR-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
PRR14L | SNV | Missense_Mutation | rs373090316 | c.4571N>A | p.Arg1524Gln | p.R1524Q | Q5THK1 | protein_coding | deleterious(0) | probably_damaging(0.993) | TCGA-B5-A1MR-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |